In 2024 the United States experienced widespread reports of medication shortages relating to supply chain disturbances. One such shortage impacted naltrexone, a medication used in the United States and Canada to treat opioid dependence and a variety of other conditions. This shortage, during the height of an opioid abuse epidemic, lead to the tracking of where pharmaceutical companies supplying to the United States and Canada source poppy straw, the agricultural product used.
